SPDR S&P Biotech ETF (XBI)

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Ticker
XBI
Exchange
AMEX
Sector
Financial Services
Industry
Asset Management
Market cap
$8.07B
52-week range
$106.30 - $169.89

Valuation

Share price
$152.21 (close of Nov 6, 2026)
Enterprise value
$8.07B

Price performance

PeriodChange
1 day+2.57%
5 days-2.42%
1 month+0.87%
3 months-1.48%
6 months+10.55%
Year to date+24.83%
1 year+39.27%
3 years+117.82%
5 years+15.91%
10 years+177.40%
All time+827.17%

Short interest

As of
Oct 15, 2026
Shares short
69.90M
Days to cover
6.58
Change since prior report
-5.80%
Source
FINRA consolidated short interest

Investor relations

Filings and sources

Earnings calendar
All upcoming reports

Similar companies

BlackRock, Inc. (BLK) · Blackstone Inc. (BX) · Brookfield Corp (BN) · KKR & Co. Inc. (KKR) · Apollo Global Management, Inc. (APO) · State Street Corp (STT) · Ameriprise Financial Inc (AMP) · Ares Management Corp (ARES)

All Financial Services companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades